Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion description "[Further, vemurafenib reduced the expression of IL-1 protein in melanoma cell lines and most notably in human tumor biopsies from 11 of 12 melanoma patients undergoing inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion evidence source_evidence_literature NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion SIO_000772 22850568 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion wasDerivedFrom befree-20140225 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion wasGeneratedBy ECO_0000203 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.